scanX
Strides Pharma Science
add_icon

Strides Pharma Science

1,003.80
+6.60
(0.66%)
Market Cap
9,252.30 Cr
PE Ratio
14.46
Volume
2,60,563.00
Day High - Low
1,019.70 - 991.00
52W High-Low
1,231.00 - 768.65
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
9,252.30 Cr
EPS
60.34
PE Ratio
14.46
PB Ratio
2.95
Book Value
337.15
EBITDA
1,076.00
Dividend Yield
0.50 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
18.24
Debt to Equity
0.64
Analyst Rating and Forecast
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Strides Pharma Science Q4FY26 Earnings Call Audio Available7 days ago
Strides Pharma Science Limited has released the audio recording of its earnings call for the quarter ended June 30, 2026. The session, held on July 31, 2026, discussed unaudited financial results under SEBI LODR Regulations 30 and 46.
positive
Strides Pharma Science Q1FY26 Results8 days ago
Strides Pharma Science reports Q1FY26 standalone net profit of ₹2,113.26 lakh, up 16% YoY. Revenue rises to ₹20,870.93 lakh, driven by operational growth.
positive
Strides Pharma Q1FY26: Profit up 56% YoY9 days ago
Strides Pharma Science reports consolidated net profit of ₹1,654.93 million for Q1FY26, driven by a ₹742.07 million gain from Pivot Path stake dilution. Revenue rose 13% YoY to ₹12,654 million.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,945.00
#1 4,66,670.65
38.50
#1 61,673.90
12.69
#1 11,565
26.53
51.95
Divis Laboratories
8,275.00
2,19,675.25
75.25
11,067.00
13.95
2,568
65.50
72.74
Torrent Pharmaceuticals
4,924.00
1,87,293.13
87.60
13,886.20
20.34
2,138
3.28
51.57
Cipla
1,463.80
1,18,252.40
35.51
29,044.60
2.24
3,870
-39.18
56.39
Zydus Life Science
1,114.20
1,12,114.59
21.54
27,657.90
17.64
5,026
7.82
48.49
Lupin
2,363.50
1,08,066.91
#1 20.42
29,038.90
#1 26.75
5,356
16.00
43.00
Mankind Pharma
2,456.00
1,01,431.81
48.56
14,636.40
14.85
1,938
29.13
45.26
Laurus Labs
1,844.30
99,565.75
90.98
6,867.80
22.01
890
#1 123.93
78.95
Dr Reddys Laboratories
1,172.00
97,823.22
30.81
35,058.60
3.90
4,158
-69.10
38.76
Aurobindo Pharma
1,658.00
95,397.65
24.88
34,145.20
5.56
3,503
25.21
65.27

Automatic Screeners on ScanX

Community
Resistance 1 Breached
Growth Rate
Revenue Growth
8.33 %
Net Income Growth
40.33 %
Cash Flow Change
2.65 %
ROE
15.22 %
ROCE
-1.27 %
EBITDA Margin (Avg.)
15.30 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
314
613
729
856
980
815
931
897
802
692
791
805
1,266
478
530
862
662
696
842
760
641
839
834
845
922
702
744
805
952
954
954
933
1,014
939
1,035
1,075
1,030
4,354
1,195
1,160
1,206
1,128
1,248
1,302
1,333
1,334
Expenses
274
564
628
728
855
676
730
602
577
595
688
627
604
448
496
516
572
612
610
574
772
648
662
712
773
850
818
833
944
1,002
844
892
879
802
1,054
886
888
866
987
946
1,000
910
999
962
1,090
1,037
EBITDA
40
50
101
128
125
140
201
295
225
97
103
178
663
30
34
346
90
84
232
187
-131
191
173
133
149
-148
-75
-28
8
-49
110
41
135
136
-18
189
142
3,488
209
215
206
218
249
340
243
297
Operating Profit %
11 %
3 %
7 %
13 %
8 %
14 %
16 %
17 %
15 %
10 %
11 %
16 %
10 %
5 %
5 %
10 %
7 %
11 %
15 %
22 %
-25 %
17 %
17 %
14 %
15 %
-23 %
-13 %
-5 %
-9 %
-7 %
6 %
-3 %
11 %
14 %
-5 %
12 %
15 %
18 %
15 %
18 %
16 %
19 %
18 %
19 %
18 %
18 %
Depreciation
20
32
36
40
39
42
44
31
38
35
37
38
44
29
31
28
30
43
42
44
45
49
53
53
52
55
57
61
61
60
62
60
61
60
60
49
48
47
49
48
49
49
50
51
53
56
Interest
15
28
34
54
62
56
58
44
48
52
49
50
46
17
17
22
23
35
40
40
40
37
37
35
42
42
44
42
50
55
68
58
81
76
79
70
71
73
74
52
50
48
46
43
42
41
Profit Before Tax
33
19
69
68
24
41
98
220
140
10
17
90
573
-16
-14
296
37
6
149
104
-217
105
83
46
55
-244
-175
-131
-103
-163
-20
-78
-7
0
-157
70
23
3,369
86
114
106
122
153
246
148
200
Tax
22
9
34
10
20
9
13
24
8
4
5
2
-5
-14
-6
-0
-8
3
7
11
-11
3
6
11
12
-36
-7
-5
-132
-28
-38
4
7
10
-7
16
13
19
14
24
21
17
22
37
19
34
Net Profit
11
10
35
58
4
33
85
196
132
6
12
88
578
-3
-9
296
45
3
142
92
-207
102
77
35
44
-209
-168
-127
29
-135
19
-82
-14
-9
-150
54
10
3,350
72
90
86
106
132
208
129
166
EPS in ₹
1.91
1.34
4.44
6.59
1.74
2.91
8.29
20.96
12.57
0.06
0.96
9.55
63.56
-0.48
-1.34
32.77
5.31
0.41
15.94
10.48
-22.77
11.56
9.03
4.22
5.14
-22.88
-18.12
-13.55
3.25
-15.13
2.54
-8.86
-1.06
-0.79
-14.54
5.43
1.98
364.64
7.81
9.56
8.92
10.81
13.84
21.93
13.77
17.02
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
2,475
7,659
8,105
6,708
7,980
6,152
7,015
6,976
6,638
5,840
6,049
6,927
Fixed Assets
701
2,499
2,980
2,977
3,648
2,099
2,219
2,347
2,311
1,865
1,899
2,101
Current Assets
1,429
3,595
3,792
2,484
3,049
2,372
2,817
3,362
3,243
2,969
3,099
3,613
Capital Work in Progress
171
1,200
780
620
453
413
447
291
151
162
207
447
Investments
561
1,260
1,525
588
702
549
697
540
490
303
409
291
Other Assets
1,041
2,700
2,821
2,524
3,177
3,091
3,651
3,798
3,687
3,510
3,534
4,088
Total Equity & Liabilities
2,475
7,659
8,105
6,708
7,980
6,152
7,015
6,976
6,638
5,840
6,049
6,927
Current Liabilities
1,020
1,940
3,104
1,899
2,662
2,545
2,738
3,412
2,990
2,879
2,592
2,896
Non Current Liabilities
291
2,813
2,119
2,191
2,516
1,012
1,463
1,181
1,475
889
871
882
Total Equity
1,164
2,906
2,882
2,618
2,802
2,595
2,814
2,383
2,173
2,072
2,587
3,149
Reserve & Surplus
1,085
2,774
2,659
2,374
2,559
2,438
2,687
2,269
2,105
2,034
2,460
3,015
Share Capital
60
89
89
90
90
90
90
90
90
92
92
92
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
-288
812
-596
-259
110
-184
-56
45
133
-143
-49
76
Investing Activities
50
-2,205
-1,222
570
-145
1,321
-522
-119
302
-150
-90
-173
Operating Activities
83
73
288
187
60
205
481
-258
44
701
684
703
Financing Activities
-421
2,944
338
-1,016
194
-1,709
-16
421
-214
-693
-643
-453
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
29.67 %
29.62 %
29.60 %
29.60 %
30.60 %
30.37 %
31.07 %
30.89 %
28.27 %
28.07 %
27.78 %
27.39 %
25.88 %
25.86 %
25.84 %
26.82 %
28.30 %
28.30 %
27.86 %
27.86 %
27.91 %
27.91 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.05 %
0.05 %
0.05 %
0.05 %
0.00 %
0.00 %
24.57 %
26.71 %
30.08 %
28.48 %
28.32 %
28.02 %
28.51 %
29.52 %
28.68 %
28.39 %
DIIs
14.82 %
13.23 %
14.22 %
14.85 %
12.40 %
9.82 %
13.59 %
18.84 %
18.29 %
20.00 %
18.22 %
17.56 %
18.04 %
18.56 %
18.24 %
16.92 %
13.72 %
13.30 %
12.98 %
13.02 %
14.45 %
15.41 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Public / Retail
14.01 %
16.64 %
17.89 %
20.42 %
21.82 %
22.29 %
22.40 %
22.43 %
25.51 %
24.93 %
23.39 %
22.65 %
21.19 %
20.87 %
18.57 %
20.86 %
21.52 %
22.10 %
22.44 %
21.42 %
20.78 %
20.42 %
Others
41.49 %
40.51 %
38.29 %
35.12 %
35.19 %
37.51 %
32.88 %
27.77 %
27.86 %
26.93 %
30.60 %
32.39 %
10.32 %
8.00 %
7.26 %
6.90 %
8.14 %
8.27 %
8.20 %
8.17 %
8.17 %
7.85 %
No of Share Holders
74,074
96,976
1,06,927
1,25,553
1,33,190
1,34,718
1,30,682
1,23,964
1,20,916
1,12,775
1,01,638
91,182
84,695
91,917
96,009
1,14,236
95,125
92,889
91,206
85,589
86,616
94,856

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 4.5 2 3 14 2.5 0.00 1.5 2.5 4 5
Dividend Yield (%) 0.69 0.42 0.93 1.66 0.72 0.00 0.19 0.37 0.43 0.5

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
14 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
 14 Aug 2026 1,077.90 1,007.05
18 Jul 2018 CHANGE OF NAME Change Of Name
NA
 18 Jul 2018 157.88 157.88
06 Aug 2021 DIVIDEND Dividend
₹ 2.50 /share
 05 Aug 2021 356.08 342.65
04 Aug 2023 DIVIDEND Dividend
₹ 1.50 /share
 04 Aug 2023 165.46 194.41
28 Aug 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
 28 Aug 2023 192.90 193.20
09 Sept 2024 DIVIDEND Dividend
₹ 2.50 /share
 09 Sept 2024 370.78 596.11
10 Sept 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
 10 Sept 2024 488.59 572.84
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 25 Sept 2024 597.66 611.33
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 24 Oct 2024 719.52 683.02
30 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 30 Jan 2025 628.20 608.70
22 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 22 May 2025 663.35 694.95
22 Jul 2025 DIVIDEND Dividend
₹ 4.00 /share
 22 Jul 2025 694.95 889.65
29 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 29 Jul 2025 877.90 922.50
07 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 07 Aug 2025 865.50 805.65
31 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 31 Oct 2025 818.05 849.95
30 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 30 Jan 2026 864.80 808.95
18 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 18 May 2026 1,155.85 1,154.00
31 Jul 2026 DIVIDEND Dividend
₹ 5.00 /share
 31 Jul 2026 1,154.00 1,073.40
31 Jul 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 31 Jul 2026 1,030.60 1,073.40

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome6 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication8 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome9 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation9 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release9 days ago
Outcome Of Board Meeting Of The Company Held On July 31 20269 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 24, 2026
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2026 Amongst Other Matters.Jul 24, 2026
Business Responsibility and Sustainability Reporting (BRSR)Jul 21, 2026
Notice Of 35Th Annual General MeetingJul 21, 2026
Reg. 34 (1) Annual Report.Jul 21, 2026
Company Has Fixed The Record Date For Final Dividend For FY26 As Friday July 31 2026Jul 20, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2026
Announcement under Regulation 30 (LODR)-RestructuringJul 03, 2026
Announcement under Regulation 30 (LODR)-RestructuringJun 27, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 27, 2026
Closure of Trading WindowJun 24, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 08, 2026
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Reminder To Shareholders Regarding Unclaimed Dividends And Transfer To IEPFJun 01, 2026
Intimation Of Effective Date For The Scheme Of Demerger Involving Arco Lab Private Limited (Arco Lab) And Pivot Path Private Limited (Pivot Path)Jun 01, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 21, 2026
Completion Of US-FDA Inspection At The CompanyS Flagship Facility In BangaloreMay 20, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 20, 2026
Pronouncement Of Order By The HonBle NCLT Bengaluru Bench Regarding Scheme Of Arrangement For Demerger Of Demerged Undertaking Of Arco Lab Private Limited A Wholly Owned Subsidiary Of Strides Pharma Science Limited.May 20, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 19, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 18, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 18, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On May 18 2026May 18, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 18, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 18, 2026
Rotation Of Statutory Auditors In FY28 May 18, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 18, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 18, 2026
Corporate Action-Board approves DividendMay 18, 2026
Outcome Of Board Meeting Of The Company Held On May 18 2026 May 18, 2026
Update To Earnings Call Intimation Dated May 11 2026 - Correction In The US TimeMay 18, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 11, 2026
Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 11, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 02, 2026
Closure of Trading WindowMar 25, 2026
Disclosure Under Regulation 30 Of SEBI Listing RegulationsMar 17, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 17, 2026
Announcement under Regulation 30 (LODR)-Updates on AcquisitionFeb 17, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Feb 05, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 05, 2026

Technical Indicators

RSI(14)
Neutral
40.89
ATR(14)
Less Volatile
40.89
STOCH(9,6)
Neutral
21.33
STOCH RSI(14)
Neutral
27.70
MACD(12,26)
Bearish
-4.85
ADX(14)
Strong Trend
28.76
UO(9)
Bearish
39.85
ROC(12)
Downtrend And Accelerating
-3.55
WillR(14)
Neutral
-70.22
Bearish
5
Neutral
3
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104